Acadia Pharmaceuticals Inc (ACAD) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

ACAD ratio: 63%

100%

ACAD beat 22 of 35 last estimates

Date of next report: Feb 25, 2025

Estimate for Q4 24: $0.22

Implied change from Q3 24: +10.00%

Implied change from Q4 23: -21.43%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 6, 2024	$0.2 / $0.13	$0.07 / 53.85%
Q2 24	Aug 6, 2024	$0.2 / $0.16	$0.04 / 25%
Q1 24	May 8, 2024	$0.1 / $0.04	$0.06 / 150%
Q4 23	Feb 27, 2024	$0.28 / $0.32	$-0.04 / -12.5%
Q3 23	Nov 2, 2023	$-0.4 / $-0.43	$0.03 / 6.98%
Q2 23	Aug 2, 2023	$0.01 / $-0.12	$0.13 / 108.33%
Q1 23	May 8, 2023	$-0.27 / $-0.21	$-0.06 / -28.57%
Q4 22	Feb 27, 2023	$-0.26 / $-0.25	$-0.01 / -4%

Data Vendor: Xignite Logo